Immunovant, Inc.·4

Aug 19, 4:46 PM ET

Pande Atul 4

4 · Immunovant, Inc. · Filed Aug 19, 2022

Insider Transaction Report

Form 4
Period: 2022-08-17
Pande Atul
Director
Transactions
  • Award

    Common Stock

    2022-08-17+21,05982,985 total
  • Award

    Stock Option (right to buy)

    2022-08-17+31,66831,668 total
    Exercise: $4.99Exp: 2032-08-17Common Stock (31,668 underlying)
Footnotes (3)
  • [F1]Represents the number of shares underlying restricted stock units awards ("RSUs").
  • [F2]The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
  • [F3]The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date.

Documents

1 file
  • 4
    wf-form4_166094195240810.xmlPrimary

    FORM 4